These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38025154)

  • 41. Catheter ablation of frequent monomorphic ventricular arrhythmias in Andersen-Tawil syndrome: case report and focused literature review.
    Keegan R; Onetto L; Gregorietti F; Urruti R; Di Biase L
    J Interv Card Electrophysiol; 2023 Apr; 66(3):729-736. PubMed ID: 34665385
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drug-induced torsade de pointes.
    Raehl CL; Patel AK; LeRoy M
    Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral flecainide for suppression of ventricular arrhythmias.
    Vanhaleweyk G; Balakumaran K; Lubsen J; Roelandt J; Hugenholtz PG
    Cardiology; 1984; 71(1):30-9. PubMed ID: 6722846
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acquired long QT syndrome and ventricular tachycardia in a patient on flecainide therapy.
    Son CW; Lee SH; Shin DG; Hong GR; Park JS
    J Cardiol Cases; 2011 Jun; 3(3):e137-e142. PubMed ID: 30532854
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cellular basis for electrocardiographic and arrhythmic manifestations of Andersen-Tawil syndrome (LQT7).
    Tsuboi M; Antzelevitch C
    Heart Rhythm; 2006 Mar; 3(3):328-35. PubMed ID: 16500306
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Arrhythmias in the intensive care patient.
    Trappe HJ; Brandts B; Weismueller P
    Curr Opin Crit Care; 2003 Oct; 9(5):345-55. PubMed ID: 14508146
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of Loss-Of-Function
    Le Tanno P; Folacci M; Revilloud J; Faivre L; Laurent G; Pinson L; Amedro P; Millat G; Janin A; Vivaudou M; Roux-Buisson N; Fauré J
    Front Genet; 2021; 12():773177. PubMed ID: 34899860
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Coexistence of Andersen-Tawil Syndrome with Polymorphisms in hERG1 Gene (K897T) and SCN5A Gene (H558R) in One Family.
    Jagodzińska M; Szperl M; Ponińska J; Kosiec A; Gajda R; Kukla P; Biernacka EK
    Ann Noninvasive Electrocardiol; 2016 Mar; 21(2):189-95. PubMed ID: 26109178
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Flecainide for recurrent malignant ventricular arrhythmias in two siblings with Andersen-Tawil syndrome.
    Bökenkamp R; Wilde AA; Schalij MJ; Blom NA
    Heart Rhythm; 2007 Apr; 4(4):508-11. PubMed ID: 17399642
    [No Abstract]   [Full Text] [Related]  

  • 50. Clinical and electrophysiologic assessment of oral flecainide acetate for recurrent ventricular tachycardia: evidence for exacerbation of electrical instability.
    Oetgen WJ; Tibbits PA; Abt ME; Goldstein RE
    Am J Cardiol; 1983 Oct; 52(7):746-50. PubMed ID: 6624666
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Arrhythmogenic effect of flecainide toxicity.
    Courand PY; Sibellas F; Ranc S; Mullier A; Kirkorian G; Bonnefoy E
    Cardiol J; 2013; 20(2):203-5. PubMed ID: 23558880
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proarrhythmic Effects Of Antiarrhythmic Drugs: Case Study Of Flecainide Induced Ventricular Arrhythmias During Treatment Of Atrial Fibrillation.
    Barman M
    J Atr Fibrillation; 2015 Dec; 8(4):1091. PubMed ID: 27957216
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Paroxysmal bidirectional ventricular tachycardia with tachycardiomyopathy in a pregnant woman.
    Walker NL; Cobbe SM; McGavigan AD
    Acta Cardiol; 2009 Jun; 64(3):419-22. PubMed ID: 19593958
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Complex Arrhythmia Syndrome in a Knock-In Mouse Model Carrier of the N98S
    Tsai WC; Guo S; Olaopa MA; Field LJ; Yang J; Shen C; Chang CP; Chen PS; Rubart M
    Circulation; 2020 Nov; 142(20):1937-1955. PubMed ID: 32929985
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Successful treatment of frequent premature ventricular contractions and non-sustained ventricular tachycardia with verapamil and flecainide in
    Maruo Y; Saito Y; Nishino I; Takeda A
    Eur Heart J Case Rep; 2023 Oct; 7(10):ytad509. PubMed ID: 37881357
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Flecainide: one-year efficacy in patients with chronic ventricular arrhythmias.
    Vanhaleweyk G; Balakumaran K; Lubsen J; ten Cate FJ; Jovanovic A; Hagemeijer F; Withagen A; Polak BC; Roelandt J; Hugenholtz PG
    Eur Heart J; 1984 Oct; 5(10):814-23. PubMed ID: 6499854
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Delayed repolarization syndrome.
    Schweitzer P; Mark H
    Am J Med; 1983 Sep; 75(3):393-401. PubMed ID: 6614027
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of flecainide on exercise-induced ventricular arrhythmias and recurrences in genotype-negative patients with catecholaminergic polymorphic ventricular tachycardia.
    Watanabe H; van der Werf C; Roses-Noguer F; Adler A; Sumitomo N; Veltmann C; Rosso R; Bhuiyan ZA; Bikker H; Kannankeril PJ; Horie M; Minamino T; Viskin S; Knollmann BC; Till J; Wilde AA
    Heart Rhythm; 2013 Apr; 10(4):542-7. PubMed ID: 23286974
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of flecainide, sotalol, and verapamil in the treatment of right ventricular tachycardia in patients without overt cardiac abnormality.
    Gill JS; Mehta D; Ward DE; Camm AJ
    Br Heart J; 1992 Oct; 68(4):392-7. PubMed ID: 1449923
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.